BioCentury | Oct 20, 2020
Deals
Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta
...Therapeutics Inc. will become a publicly traded entity by merging with special purpose acquisition company FS Development Corp....